+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pancreatin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031- (By Derivatives Coverage, Geographic Coverage and By Company)

  • PDF Icon

    Report

  • 288 Pages
  • September 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 6007931
The global pancreatin market is poised for steady growth due to its wide-ranging applications in the healthcare and pharmaceutical sectors.The global pancreatin market is poised for steady growth, projected to reach $118.99 million in 2024 and $175.8 million by 2031, reflecting a compound annual growth rate (CAGR) of 5.70%. Pancreatin, an enzyme blend produced by the pancreas, plays a crucial role in breaking down proteins, fats, and carbohydrates, aiding digestion and absorption of nutrients. This enzyme has proven benefits for both human and animal health, making it an essential component in various industries, including functional foods, pharmaceuticals, animal feed, and dietary supplements.

Pancreatin is a mixture of key enzymes such as protease, lipase, and amylase, which facilitate the digestion of essential nutrients. These enzymes are vital for converting nutrients into energy and promoting the absorption of necessary vitamins and minerals. The health benefits of pancreatin have fueled its demand in sectors focused on improving digestive health, particularly in pharmaceuticals and nutraceuticals.

One of the main drivers of pancreatin demand is the increasing incidence of lifestyle-related health disorders. Modern lifestyles, characterized by unhealthy diets, lack of exercise, and high-stress levels, have led to a growing number of digestive issues. People are increasingly turning to preventive health measures and dietary supplements to manage their digestive health. This trend has created a growing market for digestive enzymes such as pancreatin, which helps alleviate symptoms of poor digestion and supports overall wellness.

Another factor contributing to the market's growth is the rise of food sensitivities and intolerances. As people face longer working hours and more stressful environments, their bodies may struggle to digest certain foods. This has led to an increased need for digestive enzyme supplements, including pancreatin, especially among individuals who are prone to food sensitivities or intolerances. In this context, pancreatin supplementation has become essential for those looking to maintain their digestive health.

Key Trends in the Pancreatin Market

One of the key trends in the pancreatin market is the use of this enzyme as a treatment for various lifestyle disorders. Pancreatin is derived from enzymes produced by the pancreas, including trypsin, amylase, lipase, ribonuclease, and protease. These enzymes are crucial for the digestion of proteins, starch, and fats. The rising prevalence of lifestyle-related diseases, such as obesity and gallstones, has highlighted the importance of pancreatin in managing conditions like acute and chronic pancreatitis. These pancreatic disorders, along with other digestive ailments, are expected to become more common due to increasingly hectic lifestyles and higher levels of stress.

The consumption of alcohol has also played a significant role in the rising incidence of pancreatic disorders. As alcohol intake increases, the pancreas becomes more susceptible to injury, leading to a higher risk of pancreatitis. Among younger generations, the growing trend of alcohol consumption has put them at an increased risk for pancreatic disorders, further driving the demand for pancreatin. This enzyme has been effective in mitigating the effects of digestive disorders and supporting those who suffer from pancreatic conditions.

Pancreatin as a Dietary Supplement

In addition to its therapeutic uses, pancreatin has gained popularity as a dietary supplement among health-conscious consumers. Sedentary lifestyles and the consumption of unhealthy foods have led to a growing interest in dietary supplements that support digestion and overall health. The demand for health supplements has risen, particularly in the performance and nutrition markets. Athletes and fitness enthusiasts, in particular, rely on pancreatin to improve their protein absorption and enhance muscle recovery.

Protein is a critical macronutrient for muscle repair and growth. For individuals with high protein requirements, such as athletes, it is essential that their bodies can efficiently digest and absorb protein. Pancreatin aids in the breakdown of protein, ensuring that it can be effectively utilized by the body. Without adequate enzymatic support, undigested protein is excreted, which is particularly problematic for those with higher protein needs. As a result, dietary supplements that contain a blend of enzymes, including pancreatin, have become increasingly popular among athletes and health-conscious individuals.

Technological Advancements and Opportunities

Advancements in technology have opened new avenues for pancreatin manufacturers. Historically, enzyme supplements contained only single ingredients, but modern supplements now often include multiple enzymes in one product. These enzyme blends have gained popularity due to increased awareness of the health benefits of enzymes. This presents an opportunity for manufacturers to innovate and create new products that combine enzymes from animal, plant, and microbial sources.

Microbial enzymes, in particular, have gained attention for their potential applications in various industries. Many microbial enzymes remain unexplored, providing a significant opportunity for further research and development. These enzymes can be used in the food industry to improve product quality and meet the diverse needs of consumers. Additionally, manufacturers are focusing on developing condition-specific enzymes to cater to individuals with specific allergies or sensitivities, further expanding the market for pancreatin.

In response to global challenges, such as animal diseases, some companies have shifted to using microbial sources for enzyme production. For example, the outbreak of diseases affecting pigs has prompted manufacturers to explore microbial alternatives, reducing reliance on animal-based enzymes. This shift has the potential to reduce costs and enhance the sustainability of enzyme production, creating new opportunities for pancreatin suppliers.

Risks Associated with Pancreatin Consumption

Despite its benefits, pancreatin consumption is not without risks. Some individuals may experience side effects such as nausea, vomiting, diarrhea, or gastrointestinal discomfort. In rare cases, high doses of pancreatin can lead to an increase in uric acid levels, potentially causing colon damage. Additionally, individuals with allergies to pork proteins should avoid pancreatin derived from porcine sources.

Pancreatin is also heat-sensitive, meaning it should not be mixed with hot food or beverages, as heat can deactivate the enzymes. Furthermore, there is limited information on the effects of pancreatin on pregnant or breastfeeding women, making it essential for consumers to exercise caution and consult healthcare professionals before use.

Regional Insights

Europe and North America are key regions driving the growth of the pancreatin market. In Europe, countries like Germany, the United Kingdom, and France are experiencing increasing demand for pancreatin due to the prevalence of carbohydrate-rich diets and alcohol consumption. Sedentary lifestyles and unsatisfactory dietary habits among the working population have further accelerated the demand for digestive enzyme supplements in these countries.

Similarly, in North America, the fast-food culture and the affordability of unhealthy, processed foods have led to widespread digestive health issues. As a result, the demand for pancreatin supplements has grown, particularly in the United States. In this region, socio-economic disparities make it challenging for many individuals to access healthy, nutritious food, increasing the reliance on enzyme supplements like pancreatin to support digestion.

Category Insights

Pancreatin is primarily sourced from pigs (porcine) and cows (bovine). Among these sources, porcine-derived pancreatin dominates the market, accounting for the majority of production and sales. This is largely due to the higher availability and efficiency of porcine sources for enzyme extraction.

In terms of applications, the pharmaceutical industry holds the largest share of the pancreatin market. The enzyme's ability to treat digestive disorders and support pancreatic health has made it a valuable ingredient in various pharmaceutical products. Nutraceuticals also represent a growing segment, with increasing consumer interest in dietary supplements and overall wellness.

Competitive Landscape

The pancreatin market is highly competitive, with numerous players focusing on the development of high-quality enzyme products for pharmaceutical and nutraceutical applications. Companies are investing in research and development to improve enzyme extraction processes, reduce costs, and introduce innovative products. Several key players are also exploring sustainable enzyme sources, such as microbial enzymes, to mitigate the risks associated with animal-based enzymes.

Key companies profiled

  • Biovencer Healthcare Private Limited
  • Nordmark
  • Fengchen Group Co., Ltd.
  • Biozyme
  • Sichuan Biosyn Pharmaceutical Co., Ltd.
  • Bioseutica
  • Wellona Pharma
  • Shreeji Pharma International
  • Hetero Healthcare Limited
  • Creative Enzymes
  • Baoding Faithful Industry Co. Ltd.
  • SG Pharma Pvt. Ltd.
  • Provita Nutrition and Health Inc.
  • Hepalink Group
  • NOW® Foods
  • Bio Basic Inc.
  • Sichuan Deebio Pharmaceutical Co., Ltd.
  • Enzyme Bioscience Pvt. Ltd
  • Umang Pharmaceuticals
  • Antozyme Biotech Pvt Ltd

Pancreatin Industry Research by Category

By Form:

  • Powder
  • Pellets

By Source:

  • Porcine
  • Bovine

By Application:

  • Pharmaceuticals
  • Nutraceuticals

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Pancreatin Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2019 - 2023
3.1. Global Average Price Analysis, by Form, US$ Per Unit, 2019 - 2023
3.2. Prominent Factor Affecting Pancreatin Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Global Pancreatin Market Outlook, 2019 - 2031
4.1. Global Pancreatin Market Outlook, by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Powder
4.1.1.2. Pellets
4.2. Global Pancreatin Market Outlook, by Source, Value (US$ Mn), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Porcine
4.2.1.2. Bovine
4.3. Global Pancreatin Market Outlook, by Application, Value (US$ Bn, 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Pharmaceuticals
4.3.1.2. Nutraceuticals
4.4. Global Pancreatin Market Outlook, by Region, Value (US$ Mn) and Volume (Tons), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. North America
4.4.1.2. Europe
4.4.1.3. Asia Pacific
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
5. North America Pancreatin Market Outlook, 2019 - 2031
5.1. North America Pancreatin Market Outlook, by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. Powder
5.1.1.2. Pellets
5.2. North America Pancreatin Market Outlook, by Source, Value (US$ Mn), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Porcine
5.2.1.2. Bovine
5.3. North America Pancreatin Market Outlook, by Application, Value (US$ Bn, 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Pharmaceuticals
5.3.1.2. Nutraceuticals
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. North America Pancreatin Market Outlook, by Country, Value (US$ Mn) and Volume (Tons), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. U.S. Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
5.4.1.2. U.S. Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
5.4.1.3. U.S. Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
5.4.1.4. Canada Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
5.4.1.5. Canada Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
5.4.1.6. Canada Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Pancreatin Market Outlook, 2019 - 2031
6.1. Europe Pancreatin Market Outlook, by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. Powder
6.1.1.2. Pellets
6.2. Europe Pancreatin Market Outlook, by Source, Value (US$ Mn), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Porcine
6.2.1.2. Bovine
6.3. Europe Pancreatin Market Outlook, by Application, Value (US$ Bn, 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Pharmaceuticals
6.3.1.2. Nutraceuticals
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Europe Pancreatin Market Outlook, by Country, Value (US$ Mn) and Volume (Tons), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. Germany Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
6.4.1.2. Germany Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
6.4.1.3. Germany Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
6.4.1.4. U.K. Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
6.4.1.5. U.K. Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
6.4.1.6. U.K. Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
6.4.1.7. France Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
6.4.1.8. France Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
6.4.1.9. France Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
6.4.1.10. Italy Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
6.4.1.11. Italy Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
6.4.1.12. Italy Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
6.4.1.13. Turkey Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
6.4.1.14. Turkey Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
6.4.1.15. Turkey Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
6.4.1.16. Russia Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
6.4.1.17. Russia Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
6.4.1.18. Russia Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
6.4.1.19. Rest of Europe Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
6.4.1.20. Rest of Europe Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
6.4.1.21. Rest of Europe Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Pancreatin Market Outlook, 2019 - 2031
7.1. Asia Pacific Pancreatin Market Outlook, by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. Powder
7.1.1.2. Pellets
7.2. Asia Pacific Pancreatin Market Outlook, by Source, Value (US$ Mn), 2019 - 2031
7.2.1. Key Highlights
7.2.1.1. Porcine
7.2.1.2. Bovine
7.3. Asia Pacific Pancreatin Market Outlook, by Application, Value (US$ Bn, 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Pharmaceuticals
7.3.1.2. Nutraceuticals
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Asia Pacific Pancreatin Market Outlook, by Country, Value (US$ Mn) and Volume (Tons), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. China Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
7.4.1.2. China Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
7.4.1.3. China Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
7.4.1.4. Japan Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
7.4.1.5. Japan Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
7.4.1.6. Japan Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
7.4.1.7. South Korea Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
7.4.1.8. South Korea Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
7.4.1.9. South Korea Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
7.4.1.10. India Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
7.4.1.11. India Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
7.4.1.12. India Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
7.4.1.13. Southeast Asia Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
7.4.1.14. Southeast Asia Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
7.4.1.15. Southeast Asia Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
7.4.1.16. Rest of Asia Pacific Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
7.4.1.17. Rest of Asia Pacific Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
7.4.1.18. Rest of Asia Pacific Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Pancreatin Market Outlook, 2019 - 2031
8.1. Latin America Pancreatin Market Outlook, by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. Powder
8.1.1.2. Pellets
8.2. Latin America Pancreatin Market Outlook, by Source, Value (US$ Mn), 2019 - 2031
8.2.1. Key Highlights
8.2.1.1. Porcine
8.2.1.2. Bovine
8.3. Latin America Pancreatin Market Outlook, by Application, Value (US$ Bn, 2019 - 2031
8.3.1. Key Highlights
8.3.1.1. Pharmaceuticals
8.3.1.2. Nutraceuticals
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Latin America Pancreatin Market Outlook, by Country, Value (US$ Mn) and Volume (Tons), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. Brazil Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
8.4.1.2. Brazil Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
8.4.1.3. Brazil Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
8.4.1.4. Mexico Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
8.4.1.5. Mexico Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
8.4.1.6. Mexico Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
8.4.1.7. Argentina Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
8.4.1.8. Argentina Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
8.4.1.9. Argentina Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
8.4.1.10. Rest of Latin America Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
8.4.1.11. Rest of Latin America Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
8.4.1.12. Rest of Latin America Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Pancreatin Market Outlook, 2019 - 2031
9.1. Middle East & Africa Pancreatin Market Outlook, by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
9.1.1. Key Highlights
9.1.1.1. Powder
9.1.1.2. Pellets
9.2. Middle East & Africa Pancreatin Market Outlook, by Source, Value (US$ Mn), 2019 - 2031
9.2.1. Key Highlights
9.2.1.1. Porcine
9.2.1.2. Bovine
9.3. Middle East & Africa Pancreatin Market Outlook, by Application, Value (US$ Bn, 2019 - 2031
9.3.1. Key Highlights
9.3.1.1. Pharmaceuticals
9.3.1.2. Nutraceuticals
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Middle East & Africa Pancreatin Market Outlook, by Country, Value (US$ Mn) and Volume (Tons), 2019 - 2031
9.4.1. Key Highlights
9.4.1.1. GCC Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
9.4.1.2. GCC Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
9.4.1.3. GCC Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
9.4.1.4. South Africa Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
9.4.1.5. South Africa Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
9.4.1.6. South Africa Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
9.4.1.7. Egypt Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
9.4.1.8. Egypt Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
9.4.1.9. Egypt Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
9.4.1.10. Nigeria Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
9.4.1.11. Nigeria Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
9.4.1.12. Nigeria Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
9.4.1.13. Rest of Middle East & Africa Pancreatin Market by Form, Value (US$ Mn) and Volume (Tons), 2019 - 2031
9.4.1.14. Rest of Middle East & Africa Pancreatin Market by Source, Value (US$ Mn), 2019 - 2031
9.4.1.15. Rest of Middle East & Africa Pancreatin Market by Application, Value (US$ Mn), 2019 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Company Market Share Analysis, 2024
10.2. Competitive Dashboard
10.3. Company Profiles
10.3.1. Biovencer Healthcare Private Limited
10.3.1.1. Company Overview
10.3.1.2. Product Portfolio
10.3.1.3. Financial Overview
10.3.1.4. Business Strategies and Development
10.3.2. Nordmark
10.3.2.1. Company Overview
10.3.2.2. Product Portfolio
10.3.2.3. Financial Overview
10.3.2.4. Business Strategies and Development
10.3.3. Fengchen Group Co., Ltd.
10.3.3.1. Company Overview
10.3.3.2. Product Portfolio
10.3.3.3. Financial Overview
10.3.3.4. Business Strategies and Development
10.3.4. Biozyme
10.3.4.1. Company Overview
10.3.4.2. Product Portfolio
10.3.4.3. Financial Overview
10.3.4.4. Business Strategies and Development
10.3.5. Sichuan Biosyn Pharmaceutical Co., Ltd.
10.3.5.1. Company Overview
10.3.5.2. Product Portfolio
10.3.5.3. Financial Overview
10.3.5.4. Business Strategies and Development
10.3.6. Bioseutica
10.3.6.1. Company Overview
10.3.6.2. Product Portfolio
10.3.6.3. Financial Overview
10.3.6.4. Business Strategies and Development
10.3.7. Wellona Pharma
10.3.7.1. Company Overview
10.3.7.2. Product Portfolio
10.3.7.3. Financial Overview
10.3.7.4. Business Strategies and Development
10.3.8. Shreeji Pharma International
10.3.8.1. Company Overview
10.3.8.2. Product Portfolio
10.3.8.3. Financial Overview
10.3.8.4. Business Strategies and Development
10.3.9. Hetero Healthcare Limited
10.3.9.1. Company Overview
10.3.9.2. Product Portfolio
10.3.9.3. Financial Overview
10.3.9.4. Business Strategies and Development
10.3.10. Creative Enzymes
10.3.10.1. Company Overview
10.3.10.2. Product Portfolio
10.3.10.3. Financial Overview
10.3.10.4. Business Strategies and Development
10.3.11. Baoding Faithful Industry Co. Ltd.
10.3.11.1. Company Overview
10.3.11.2. Product Portfolio
10.3.11.3. Financial Overview
10.3.11.4. Business Strategies and Development
10.3.12. SG Pharma Pvt. Ltd.
10.3.12.1. Company Overview
10.3.12.2. Product Portfolio
10.3.12.3. Financial Overview
10.3.12.4. Business Strategies and Development
10.3.13. Provita Nutrition and Health Inc.
10.3.13.1. Company Overview
10.3.13.2. Product Portfolio
10.3.13.3. Financial Overview
10.3.13.4. Business Strategies and Development
10.3.14. Hepalink Group
10.3.14.1. Company Overview
10.3.14.2. Product Portfolio
10.3.14.3. Financial Overview
10.3.14.4. Business Strategies and Development
10.3.15. NOW® Foods
10.3.15.1. Company Overview
10.3.15.2. Product Portfolio
10.3.15.3. Financial Overview
10.3.15.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Companies Mentioned

  • Antozyme Biotech Pvt Ltd
  • Umang Pharmaceuticals
  • Enzyme Bioscience Pvt. Ltd
  • Biovencer Healthcare Private Limited
  • Nordmark
  • Fengchen Group Co., Ltd.
  • Biozyme
  • Sichuan Biosyn Pharmaceutical Co., Ltd.
  • Bioseutica
  • Wellona Pharma
  • Shreeji Pharma International
  • Hetero Healthcare Limited
  • Creative Enzymes
  • Baoding Faithful Industry Co. Ltd.
  • SG Pharma Pvt. Ltd.
  • Provita Nutrition and Health Inc.
  • Hepalink Group
  • NOW® Foods
  • Bio Basic Inc.
  • Sichuan Deebio Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...